NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/03/2023
Voltar para busca
Dado oficial do USPTO
RENNANO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
25
Atualização mais recente
25/03/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 31, 42
Data de depósito
24/02/2021
Data de registro
03/05/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/05/2022
Última transação
03/05/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
CN
Examinador
THOMPSON, HEATHER
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Representantes
Michelle E. Tochtrop Pearne & Gordon LLP
Classificação técnica
Classes Nice
Classe 5Classe 31Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Vaccines; pharmaceutical preparations for the treatment of immune system related diseases and disorders; medicines for the treatment of cancer; diagnostic preparations for medical purposes; biochemical medicines for the treatment of tumorsinfectious diseasesinflammation and autoimmune diseases; medicines for human purposes for the treatment of tumorsinfectious diseasesinflammation and autoimmune diseases; drugs for medical purposes for the treatment of tumorsinfectious diseasesinflammation and autoimmune diseases; biological preparations for medical purposes for the treatment of tumorsinfectious diseasesinflammation and autoimmune diseases; active pharmaceutical ingredients being chemical and biological preparations for pharmaceutical purposesantibodies for the treatment of human and animal diseases; diagnostic preparations for medical and veterinary purposes; dietetic preparations adapted for medical use; medicines for veterinary purposes for the treatment of tumorsinfectious diseasesinflammation and autoimmune diseases
Classe 31
Live trees; live plants; live animals; poultrylive; pigslive; hamsterslive; live laboratory animals; plant seeds; fodder; litter for animals
Classe 42
Conducting early evaluation in the field of new pharmaceutical products; development of products for others; consulting services in the field of technology development in the fields of pharmaceutical research and development; research and development of new products; pharmaceutical research services; quality control inspection in the field of pharmaceutical research and development; biochemical research and analysis; research and development services in the field of antibodies; medical and scientific researchconducting clinical trials for others; biological research; development of pharmaceutical preparations and medicines; product testing; pharmaceutical products development services; evaluation of pharmaceuticals; technological researchpharmaceutical research
Publicações
Histórico de despachos e eventos da marca no USPTO.
25 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/10/2022
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
04/09/2022
XXCR
GENERIC MADRID TRANSACTION CREATED
04/09/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
03/05/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/02/2022
PUBO
PUBLISHED FOR OPPOSITION
15/02/2022
GPNX
NOTIFICATION PROCESSED BY IB
14/02/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
26/01/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
26/01/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/01/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/01/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/01/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/01/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/01/2022
RFNT
REFUSAL PROCESSED BY IB
05/11/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/10/2021
RFRR
REFUSAL PROCESSED BY MPU
08/10/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
24/09/2021
CNRT
NON-FINAL ACTION WRITTEN
23/09/2021
DOCK
ASSIGNED TO EXAMINER
19/09/2021
MAFR
APPLICATION FILING RECEIPT MAILED
01/07/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/06/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
24/06/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace RENNANO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.